Home > Healthcare > Medical Devices > Medical Supplies > Glucose Biosensors Market
Glucose Biosensors Market Share
- Report ID: GMI5300
- Published Date: Jul 2023
- Report Format: PDF
Glucose Biosensors Market Share
- Nova Biomedical
- Universal Biosensors
- Med Trust
- Roche AG
- Lifescan, Inc.
- Taidoc Technology Corporation
- Dexcom
- Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.)
Frequently Asked Questions (FAQ) :
In 2022, the glucose biosensors industry was valued at USD 12.9 billion and will grow at more than 13% CAGR from 2023 to 2032, attributed to the rising incidence of diabetes globally.
Self monitoring blood glucose devices industry was valued at over USD 6 billion in 2022, owing to surging awareness about diabetes risks, its complications, management, and control.
North America glucose biosensors market size will reach more than USD 11.7 billion by 2032, owing to rising investment by the government in diabetes care.
Major glucose biosensors industry players include Lifescan, Inc., Nova Biomedical, Taidoc Technology Corporation, Dexcom, Abbott, Trividia Health, Universal Biosensors, Med Trust, Roche AG., and i-SENS, Inc., among others.
Glucose Biosensors Market Scope
×
Get a free sample of
Glucose Biosensors Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below